ATE250670T1 - Vektor, enthält ein bei arn-polymerase-iii transcriptes virus-gen - Google Patents

Vektor, enthält ein bei arn-polymerase-iii transcriptes virus-gen

Info

Publication number
ATE250670T1
ATE250670T1 AT93401745T AT93401745T ATE250670T1 AT E250670 T1 ATE250670 T1 AT E250670T1 AT 93401745 T AT93401745 T AT 93401745T AT 93401745 T AT93401745 T AT 93401745T AT E250670 T1 ATE250670 T1 AT E250670T1
Authority
AT
Austria
Prior art keywords
iii
present
rna
polymerase iii
rna polymerase
Prior art date
Application number
AT93401745T
Other languages
English (en)
Inventor
Alain Doglio
Jean-Claude Lefebvre
Laurence Cagnon
Original Assignee
Univ Nice Sophia Antipolis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nice Sophia Antipolis filed Critical Univ Nice Sophia Antipolis
Application granted granted Critical
Publication of ATE250670T1 publication Critical patent/ATE250670T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93401745T 1993-07-06 1993-07-06 Vektor, enthält ein bei arn-polymerase-iii transcriptes virus-gen ATE250670T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93401745A EP0647716B1 (de) 1993-07-06 1993-07-06 Vektor, enthält ein bei ARN-Polymerase-III transcriptes Virus-Gen

Publications (1)

Publication Number Publication Date
ATE250670T1 true ATE250670T1 (de) 2003-10-15

Family

ID=8214731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93401745T ATE250670T1 (de) 1993-07-06 1993-07-06 Vektor, enthält ein bei arn-polymerase-iii transcriptes virus-gen

Country Status (3)

Country Link
EP (1) EP0647716B1 (de)
AT (1) ATE250670T1 (de)
DE (1) DE69333216T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2743818B1 (fr) * 1996-01-23 1998-04-10 Agronomique Inst Nat Rech Constructions d'adn et vecteurs d'expression derives du gene de l'arn va i d'adenovirus
US6291164B1 (en) 1996-11-22 2001-09-18 Invitrogen Corporation Methods for preventing inhibition of nucleic acid synthesis by pyrophosphate
AU2001275191A1 (en) 2000-05-31 2001-12-11 Chiron Corporation Method for the purification of alphavirus replicon particles
DE10046913A1 (de) * 2000-09-21 2002-04-18 Nascacell Gmbh Expressionssystem für funktionale Nukleinsäuren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE140961T1 (de) * 1989-03-16 1996-08-15 Boehringer Ingelheim Int Genetische einheiten zur inhibierung der funktion von rna
FR2687411A1 (fr) * 1992-02-13 1993-08-20 Nice Sophia Antipolis Universi Vecteur comportant un gene viral transcrit par l'arn polymerase iii, et procede de production intracellulaire d'arn.

Also Published As

Publication number Publication date
DE69333216T2 (de) 2004-06-24
EP0647716A1 (de) 1995-04-12
DE69333216D1 (de) 2003-10-30
EP0647716B1 (de) 2003-09-24

Similar Documents

Publication Publication Date Title
CY1111682T1 (el) Μεθοδοι και τροποι για την αποκτηση τροποποιημενων φαινοτυπων
CA2193094A1 (en) The cytoplasmic inhibition of gene expression
WO2004076622A3 (en) Regulation of gene expression by dna interference
ATE189264T1 (de) Chimärisches oligonukleotid und dessen verwendung zur herstellung von nukleinsäure-transkripten
CA2171759A1 (en) Methods and compositions for high protein production from recombinant dna
WO2005059093A3 (de) P ef-tu-expressionseinheiten
DE69328514T2 (de) Herstellung rekombinanter Proteine unter Verwendung von Herpes-Virus-Promotoren und VP16-Transaktivatoren
WO1996001314A3 (de) Ribozym-bibliothek, ihre herstellung und ihre verwendung
CA2557882A1 (en) Defective packaging non-oncoviral vectors based on mpmv and hiv
AU3824893A (en) Process for production of exogenous gene or its product in plant cells
CA2467801A1 (fr) Sequences nucleiques issues du genome de salmonella typhi, et leurs utilisations notamment pour le diagnostic in vitro de la presence de bacteries du genre salmonella dans les produits alimentaires
ATE250670T1 (de) Vektor, enthält ein bei arn-polymerase-iii transcriptes virus-gen
WO1994000463A3 (en) Production of hyaluronic acid by transeformed microorganisms
EP0242220A3 (en) Gene expression system
CA2037677A1 (en) Process for production of exogenous gene or its product in plant cells
EP0247145A4 (de) Vielfach amplifizierbare vektoren für hohe expression exogener dns.
KR970010968A (ko) 오리 배 세포를 이용한 에리스로포이틴의 발현 시스템
GB2331989B (en) Retroviral vectors
CA2289907A1 (en) Eukaryotic and retroviral antisense initiator elements
Thompson et al. Modulation of transcription by altered torsional stress, upstream silencers, and DNA-binding proteins.
AU4444589A (en) Expression enhancer and use thereof to increase the yield in the expression of recombinant genes
KR970001543A (ko) 신규 프로모터 및 이를 이용한 유전자 발현 방법
Knowles et al. Recombinant DNA: Gene transfer and expression techniques with industrial yeast strains.
Miyagi et al. Replication of the rat aldolase B locus differs between aldolase B-expressing and non-expressing cells
Walberg TRANSCRIPTIONAL ORGANIZATION AND IN VITRO TRANSCRIPTION OF MAMMALIAN MITOCHONDRIAL DNA.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties